Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome?
Dermatol Ther
.
2022 Jul;35(7):e15559.
doi: 10.1111/dth.15559.
Epub 2022 May 15.
Authors
Francesco Cavallo
1
,
Gabriele Roccuzzo
1
,
Gianluca Avallone
1
,
Claudio Conforti
2
,
Iris Zalaudek
2
,
Silvia Giordano
1
,
Marco Rubatto
1
,
Paolo Fava
1
,
Simone Ribero
1
,
Pietro Quaglino
1
Affiliations
1
Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.
2
Dermatology Clinic, Maggiore Hospital, University of Trieste.
PMID:
35524707
DOI:
10.1111/dth.15559
No abstract available
Publication types
Letter
MeSH terms
Humans
Melanins
Melanoma* / drug therapy
Melanoma* / pathology
Nevus, Halo*
Nivolumab / therapeutic use
Skin Neoplasms* / drug therapy
Skin Neoplasms* / pathology
Substances
Melanins
Nivolumab